Clinical Trials Directory

Trials / Unknown

UnknownNCT01796769

Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform for Improving CPAP Compliance in Low Cardiovascular Risk Sleep Apnea Patients : OPTISAS 1 Study

Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform for Improving Continuous Positive Airway Pressure (CPAP) Compliance in Low Cardiovascular Risk Sleep Apnea Patients

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
936 (estimated)
Sponsor
Fédération Française de Pneumologie · Academic / Other
Sex
All
Age
18 Years – 78 Years
Healthy volunteers
Not accepted

Summary

Targeted population: Sleep apnea patients at low cardiovascular risk newly treated by CPAP Hypothesis: Six months CPAP compliance might be greater in the telemonitoring arm compared to usual CPAP care. Main goal: To compare 6-months CPAP compliance when Sleep Apnea patients at low cardiovascular risk are randomly allocated to usual CPAP care or a multidisciplinary and coordinated follow-up based on a telemonitoring web platform.

Detailed description

Study procedures: The telemonitoring system will involve respiratory physicians, home care providers and include regular assessments of oximetry, CPAP compliance, side effects and residual events. Secured data transmission to medical staff computers and secured websites will allow easy telemonitoring. Automatic algorithms have been built-up for early adjustment of CPAP treatment in case of side effects, leaks and persistent residual events. An interim analysis will be performed when 200 patients will be included.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous Positive Airway Pressure (CPAP) in sleep apnea patientsUsual CPAP treatment in sleep apnea patients
DEVICEContinuous Positive Airway Pressure (CPAP) in sleep apnea patientsCPAP treatment with telemedicine system

Timeline

Start date
2013-02-01
Primary completion
2014-09-01
Completion
2014-12-01
First posted
2013-02-22
Last updated
2014-09-05

Locations

32 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01796769. Inclusion in this directory is not an endorsement.